Bigfoot Biomedical® Announces Initial $45 Million of a Series C Financing Led by Abbott
Retrieved on:
Monday, January 13, 2020
Bigfoot Biomedical, Inc. announced today that the company has raised $45 million in the initial tranche of a Series C equity financing.
Key Points:
- Bigfoot Biomedical, Inc. announced today that the company has raised $45 million in the initial tranche of a Series C equity financing.
- The round is led by Abbott with support from existing investors, including Quadrant Capital Advisors, Senvest Capital, Janus Henderson, and Cormorant Asset Management.
- Series C funds will also be directed toward clinical trials of future generation Bigfoot Unity systems incorporating closed-loop technology for injection users.
- We are excited to announce Abbotts deepening support of Bigfoot Biomedical with this Series C financing, said Jeffrey Brewer, chief executive officer of Bigfoot Biomedical.